These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11388708)

  • 21. Information from your family doctor. Pneumococcal conjugate vaccine: what a parent needs to know.
    Am Fam Physician; 2001 May; 63(10):2003-4. PubMed ID: 11388716
    [No Abstract]   [Full Text] [Related]  

  • 22. Cost-effectiveness of universal pneumococcal vaccination for infants in Italy.
    Marchetti M; Colombo GL
    Vaccine; 2005 Aug; 23(37):4565-76. PubMed ID: 15992969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Declining invasive pneumococcal disease in the U.S. elderly.
    McBean AM; Park YT; Caldwell D; Yu X
    Vaccine; 2005 Dec; 23(48-49):5641-5. PubMed ID: 16111788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Childhood vaccination update. A new weapon against pneumococcal bacteria.
    Waldrop TB
    Adv Nurse Pract; 2001 Feb; 9(2):34-6, 39. PubMed ID: 12416052
    [No Abstract]   [Full Text] [Related]  

  • 25. Infant immunisation with a pneumococcal conjugate vaccine: from the age of two months, for all infants.
    Prescrire Int; 2006 Dec; 15(86):227-33. PubMed ID: 17167934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HHS-CDC news: Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--US, 1998-2003.
    Ann Pharmacother; 2005 Nov; 39(11):1967-8. PubMed ID: 16219891
    [No Abstract]   [Full Text] [Related]  

  • 27. Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7; Prevnar).
    Isaacman DJ; Fletcher MA; Fritzell B; Ciuryla V; Schranz J
    Vaccine; 2007 Mar; 25(13):2420-7. PubMed ID: 17049677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pneumococcal conjugate vaccine: economic issues of the introduction of a new childhood vaccine.
    Ray GT
    Expert Rev Vaccines; 2002 Jun; 1(1):65-74. PubMed ID: 12908513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on recommended use of pneumococcal conjugate vaccine.
    National Advisory Committee on Immunization
    Can Commun Dis Rep; 2002 Jan; 28(ACS-2):1-32. PubMed ID: 12728645
    [No Abstract]   [Full Text] [Related]  

  • 30. HPV vaccine recommendations.
    Committee on Infectious Diseases
    Pediatrics; 2012 Mar; 129(3):602-5. PubMed ID: 22371460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life.
    Adamkiewicz TV; Silk BJ; Howgate J; Baughman W; Strayhorn G; Sullivan K; Farley MM
    Pediatrics; 2008 Mar; 121(3):562-9. PubMed ID: 18310206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use.
    Toltzis P; Jacobs MR
    Infect Dis Clin North Am; 2005 Sep; 19(3):629-45. PubMed ID: 16102653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preventing pneumococcal disease. ACIP recommends pneumococcal polysaccharide vaccine for all adults age > or = 65.
    Whitney CG
    Geriatrics; 2003 Oct; 58(10):20-2, 25. PubMed ID: 14569639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rethinking recommendations for use of pneumococcal vaccines in adults.
    Whitney CG; Schaffner W; Butler JC
    Clin Infect Dis; 2001 Sep; 33(5):662-75. PubMed ID: 11486289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects.
    Lloyd A; Patel N; Scott DA; Runge C; Claes C; Rose M
    Eur J Health Econ; 2008 Feb; 9(1):7-15. PubMed ID: 17333089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization update: This year's changes.
    Campos-Outcalt D
    J Fam Pract; 2016 Mar; 65(3):198-200. PubMed ID: 27158692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Financing immunization of adults in the United States.
    Orenstein WA; Mootrey GT; Pazol K; Hinman AR
    Clin Pharmacol Ther; 2007 Dec; 82(6):764-8. PubMed ID: 17971821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cost-burden of paediatric pneumococcal disease in Sweden and the potential cost-effectiveness of prevention using 7-valent pneumococcal vaccine.
    Silfverdal SA; Berg S; Hemlin C; Jokinen I
    Vaccine; 2009 Mar; 27(10):1601-8. PubMed ID: 19146905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventing pneumococcal disease: a Canadian consensus conference. 16-18 February 1998.
    Can Commun Dis Rep; 1999 Feb; 25(4):25-35. PubMed ID: 10079579
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunization and the prevention of influenza and pneumococcal disease in people with diabetes.
    American Diabetes Association
    Diabetes Care; 2000 Jan; 23 Suppl 1():S91-3. PubMed ID: 12017693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.